Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-01-03 @ 8:15 PM
Study NCT ID:
NCT02865434
Status:
COMPLETED
Last Update Posted:
2021-08-12
First Post:
2016-08-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA
Sponsor:
Navidea Biopharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NAV3-21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None